Peptides for chlamydophila pneumoniae vaccine and diagnosis

Details Peptides for chlamydophila pneumoniae vaccine and diagnosis Peptides for chlamydophila pneumoniae vaccine and diagnosis

2007-05-29

2007-05-29

Ungar, Susan (Department: 1645)

Chemistry: natural resins or derivatives; peptides or proteins;

Peptides of 3 to 100 amino acid residues

C530S350000, C530S402000, C530S811000, C530S814000, C530S820000, C530S825000, C435S069700, C435S184000, C435S007100, C424S190100, C424S192100, C424S234100, C424S263100, C536S023700

Reexamination Certificate

active

10479503

ABSTRACT:
Peptides are disclosed that include SEQ ID NO:1, SEQ ID NO: 2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, and SEQ ID NO:6, or a conservative variant or mimic thereof, wherein the conservative variant or mimic specifically binds an antibody that specifically binds SEQ ID NO:1, SEQ ID NO: 2, SEQ ID NO:3, SEQ ID NO:4, SEQ ID NO:5, SEQ ID or NO:6. These peptides are of use in generating an immune response againstC. pneumoniae, or in preventing infection with againstC. pneumoniae.

REFERENCES:
patent: 5281518 (1994-01-01), Campbell et al.
patent: 5350673 (1994-09-01), Campbell et al.
patent: 5439881 (1995-08-01), Narva et al.
patent: 5686068 (1997-11-01), Melief et al.
patent: 5693488 (1997-12-01), Fang et al.
patent: 5837460 (1998-11-01), Von Feldt et al.
patent: 5869608 (1999-02-01), Caldwell et al.
patent: 6030799 (2000-02-01), Agabian et al.
patent: 6034230 (2000-03-01), Bachmaier et al.
patent: 6146839 (2000-11-01), Morikawa et al.
patent: 6165478 (2000-12-01), Izutsu et al.
patent: WO 99/45954 (1999-09-01), None
Rudinger et al, in “Peptide Hormones”, edited by Parsons, J.A., University Park Press, Jun. 1976, p. 1-6.
Jobling et al. (Mol. Microbiol. 1991, 5(7): 1755-67.
Moazed et al.,J. Infectious Dis. 175:883-890, 1997.
Murdin et al.,J. Infectious Dis. 181(Supp. 3):S544-S551, 2000.
Wong et al.,J. Clin. Microbiol. 30(7):1625-1630, 1992.
Yang et al.,Infection&Immunity61(5):2037-2040, 1993.
International Search Report from PCT/US02/17278.
Marston et al., “Discovery and characterization of a novel immunogenic Chylamydophila pneumoniae peptide reactive with murine monoclonal and human serum antibodies,”41stICAAC Abstracts, Chicago, IL, Sep. 22-25, 2001.
Marston et al., “Newly Characterized Species-Specific Immunogenic Chlamydophila pneumonia Peptide Reactive with Murine Monoclonal and Human Serum Antibodies,”Clinical and Diagnostic Laboratory Immunology, 9(2):446-452, 2002.
Naidu et al., “An immunogenic epitope of Chlamydia pneumoniae from a random phage display peptide library is reactive with both monoclonal antibody and patients sera,”Immunology Letters, 62(2):111-115, 1998.
Srivastava et al., “Selection of an Immunogenic and Protective Epitope of the PsaA Protein of Streptococcus pneumoniae Using a Phage Display Library,”Hybridoma, 19(1):23-31, 2000.
Wong et al., “Efficient Culture of Chlamydia pneumoniae with Cell Lines Derived from the Human Respiratory Tract,”Journal of Clinical Microbiology, 30(7):1625-1630, 1992.
Supplementary European Search Report issued on Sep. 19, 2005 for European Patent Application No. 02749546.4.

Affiliated with

Also associated with

Rating

Peptides for chlamydophila pneumoniae vaccine and diagnosis does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peptides for chlamydophila pneumoniae vaccine and diagnosis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides for chlamydophila pneumoniae vaccine and diagnosis will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3762406